Who are Perlara's investors?

Perlara's investors include Y Combinator, Novartis, Slow Ventures.

Where is Perlara headquartered?

Perlara is headquartered in Oakland, California, United States.

What industry is Perlara in?

Perlara operates in Healthcare.

Perlara

Perlara: building the YC for rare disease parents

Oakland, United States · Founded 2014

Healthcare

YC W16

Headquarters: Oakland, California
Employees: 1–10
Founded: 2014

Website: perlara.com
Last Round: SeedNov 2017
Rounds: 2

About

Perlara 1.0 (Feb 2014 - Feb 2019) launched early R&D joint ventures called PerlQuests with highly motivated rare disease families, companies or impact investors. We screened gene-edited patient avatars for repurposable drugs in order to build a predictive R&D engine called ArkBase. We planned to monetize programs based on ArkBase predictions by selectively spinning out asset-centric clinical development NewCos. Perlara 1.5 (March 2019 - April 2020) was the transition to a one-person virtual clinical development company and when the epalrestat and aripiprazole repurposing trials were launched at Mayo Clinic for the treatment of PMM2-CDG and NGLY1-CDDG, respectively. Perlara 2.0 (May 2020 --> The first decentralized and distributed biotech

Summary

Perlara is a Healthcare company based in Oakland, United States, founded in 2014. Its most recent funding was a Seed round in Nov 2017. Investors include Y Combinator, Novartis and Slow Ventures.